Kubota Pharmaceutical Holdings Co.,Ltd. provided earnings guidance for the fiscal year end of 2016. For the period, the company expects revenue from collaborations of JPY 897 million. Loss from operations expected to be of JPY 4,140 million. Loss before income tax expected to be of JPY 3,998 million. Net loss attributable to shareholders expected to be of JPY 3,998 million. Net loss per share expected to be of JPY 105.45.